Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
invt up 50% on a pincher
taking SUNE if it breaks 4.40
SUNE really wanting to pinch IMO. Could double. Controversy is out there, but love it or hate it it keeps coming back
RTK just broke out yesterday. Looking like a pinch
ZMLP pinching for what seems for obvious reasons. High income index will be a safe haven for ppl when the rate hike comes.
Terp as well
Ngls is pinching now
nice play yesterday, no clear sell point here. pinchers are good for a day or two on a huge move it seems
xbit another great example of a pincher momo stock. great set up and catalyst. no price target and huge gap to fill. something to learn from. be patient and jump on a good opportunity.
Roka is for sure ready to go.
My exit strategy from looking at the one year chart is to sell when Full Stochastics touches 80. I imagine it'll at least try to fill the gap to 1.7 to 1.8 before that happens.
Wifi is another one that has already pinched and hasn't given a sell signal yet. I think it'll go to Full Stochastics above 80 and above 50 day moving average.
I don't know much about these companies. I'm just playing the action on the charts.
WIFI pincher already occurred a few days ago, but no sell signal. Waiting to see STO over 80 before selling. Still a good entry here IMO
ROKA low float (1.7M), PPO ADX pincher, -dx and +dx crossover, RSI heading to 50, MACD negative and rising
Recent form 4 and high volume, e-coli testing business, looks like it could breakout and squeeze though short interest is only at 6%
I was searching for a like button to no avail. Awesome synopsis!
They usual do because they are on fast track and orphan disease status meaning less time thus less expensive. IMO
Is this in September?
20 billion is what? $5?
You looking at L2? What do you see?
Building a nice base for a solid move up. Holding its gains. These are good indicators, plus this stock has a tendency to run in the afternoon. I think we'll see a move here later. Breaking .63 is key
Seen it all week
Did anyone stick around and make a butt load of cash?
Awesome!! Thank you!!
Anyone have the L2 screenshot?!
I totally agree. I just misunderstood your first comment. You and I both want him to sell and get $15 a share. I thought it a little foreshadowing that the recent article indicating the tax asset as key to VLTC's value used the word Horizon in the heading. Horizon/Verizon lol
Why would news of him selling the company change it? Just curious. Thanks.
Who's buying EPGL right now? Sees the ask is being slapped. There must be a lot of anticipation for pending news.
Have you seen anything more beautiful?
Looks like a few more days before another solid move up. Taking a hiatus.
Lol. Either way, price action is in an uptrend.
9s expiring
L2 anyone? Please? Thank you?
I just would like the chart to show some uptrend before getting in too deep. We could see a bounce soon, but regardless of all the good sentiment, money is in the PPS, not anything else. I'll invest when others invest. It's definitely on the watch list though.
I'm not following. Why the mad rush? Where are you getting this information? Thank you in advance.
BTW, I was talking about the letter to investors. They said we'd see an increase of more than $8million in gross profit 2015. http://www.otcmarkets.com/otciq/ajax/showNewsReleaseDocumentById.pdf?id=13940
When does NTEK release q2 2015 fins? I heard they'll have a treat for investors.
Other rumors: CMCSA has released a statement saying they'll be providing 4K content of which a guy on FB said it contained content already owned by NTEK.
BTW, chart is looking bullish. Ups and downs to be expected.
LONG
Fair unbiased assessment. Thanks
One major risk is if VBL cannot begin Phase III on VB-111. They have abandoned one drug in Phase II already because it was no longer worth pursuing. That was VB-201.
But with the recent success of VB-111, it seems they'll move forward with their plan to begin Phase III mid-2015.
Why I think VBL is worth over a billion dollars:
VBL overview
As of 03/25/2015, click for up to date information from WSJ:
Market Cap $111.14 M Shares Outstanding 19.90 M Public Float 8.17 M.
VBLT's current PT as of 03/25/2015 is $11.5 from WSJ. Click for latest
Q. Why is VB-111's novel gene-therapy targeting system is so unique and valuable?
A. VBL's patented gene targeting system only targets blood vessels that feed the tumors; meaning no collateral damage or side effects as with nonspecific vectors and chemotherapies.
Q. Why VBL's novel technology is worth over a billion dollars?
A. It's an efficient, no side effects cancer drug. It has no side effects as associated with nonspecific treatments such as chemotherapy. VBL's patented and unique gene-therapy targeting system attacks and kills only the blood vessels feeding the cancer.
watch video
Q. What is VBL developing now and at what stage of development are they?
VB-111 for Glioblastoma (rGBM)--a brain cancer that affects 10,000 people/year newly diagnosed people in the USA--has FDA Fast Track Designation that will make VB-111 available earlier to patients. VB-111 is intending to begin Phase-III pivotal trial mid-2015. Future hope: VBL will have exclusivity for VB-111 until 2027 in the USA and Europe if approved for marketing, which VBL believes is highly likely given its Orphan Drug Designation along with patents already granted.
No need to sell their shares when lock expires 3/30. VB-111 cancer drug, specifically targets only the cancer cells. There are no side effects like with chemotherapy. It's first series of the drug targets rare brain cancer which gives them orphan drug approval by the FDA and FDA fast track status to make Phase III faster and more cost efficient. Phase III will start mid-year. They are always open and early about giving updates and announcements. Excellent management.
Broke $7 resistance. Good to buy now . EMA (9) diverging at $8.5. My PT near term is $8.50. GLTA
http://www.vblrx.com/cancer-programs/overview/
Vascular Biogenics beats by $0.10
http://www.seekingalpha.com/news/2390076
VBL Therapeutics' lead drug candidate successful in brain cancer study; shares up 18% premarket
http://www.seekingalpha.com/news/2390486
$VBLT is a micro-cap stock. Only $111m MC. Vb-111 oncology drug goes into Phase III the first-half of this year. $$$ http://t.co/Eisi8t7jZX